Clinical Trial Update: Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 controlled trial evaluating NGX-4010 for postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: Herpes Zoster, Neuralgia | Phase 3 | Status: COMPLETED